Explore the complex legal interaction between 180-day exclusivity and authorized generics under the Hatch-Waxman Act. Learn how this dynamic impacts drug prices, generic incentives, and patient access.
Patent term restoration lets pharmaceutical companies recover lost patent time due to FDA delays. Learn how the Hatch-Waxman Act works, who qualifies, and why it's critical for drug development.
The Federal Circuit Court controls all U.S. pharmaceutical patent appeals, shaping how generics enter the market, how patents are enforced, and whether new dosing regimens can be protected. Its rulings impact drug prices, litigation costs, and innovation.
